Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:7
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 15 条
  • [11] Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study
    Michalakis, Konstantinos
    Williams, Catherine J.
    Mitsiades, Nicholas
    Blakeman, Jennifer
    Balafouta-Tselenis, Sofia
    Giannopoulos, Aris
    Mantzoros, Christos S.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) : 308 - 313
  • [12] Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
    Ozmen, H
    Erulas, FA
    Karatas, F
    Cukurovali, A
    Yalcin, O
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 175 - 179
  • [13] Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort
    Sauver, Jennifer L. St.
    Sarma, Aruna V.
    Jacobson, Debra J.
    McGree, Michaela E.
    Lieber, Michael M.
    Girman, Cynthia J.
    Nehra, Ajay
    Jacobsen, Steven J.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (11) : 1281 - 1290
  • [14] Serum Adiponectin, C-Peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
    Schenk, Jeannette M.
    Kristal, Alan R.
    Neuhouser, Marian L.
    Tangen, Catherine M.
    White, Emily
    Lin, Daniel W.
    Thompson, Ian M.
    [J]. PROSTATE, 2009, 69 (12) : 1303 - 1311
  • [15] Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults
    Wu, TJ
    Sempos, CT
    Freudenheim, JL
    Muti, P
    Smith, E
    [J]. ANNALS OF EPIDEMIOLOGY, 2004, 14 (03) : 195 - 201